The global flow cytometry market is estimated to be valued at over USD 13.98 billion by 2033 and is projected to register a CAGR of over 7.84% during the forecast period from 2025 to 2033.

Flow cytometry is a tool used for detecting physicochemical properties of a cell or particles, based on the principle of light scattering. Cell counting, cell sorting, detection of microbes, protein engineering detection, etc. are some of the uses of flow cytometry.

The advancements in technology, adoption of flow cytometry method in research and academics, initiatives in oncology and immunology research, etc. are the driving factors aiding the flow cytometry market growth. The inclination towards adopting a more effective alternative for diagnosis of severe diseases has boosted market demand for flow cytometry techniques.

Being an advanced system, the flow cytometry should be operated by well trained and skilled personnel. The equipment maintenance expenses and expenditure assigned on personnel training are quite high resulting in limited purchasing by the majority of end-users. These factors are estimated to affect flow cytometry market growth.

The cell-based flow cytometry is estimated to dominate the market. In the current era, owing to the rising focus on cell culture, target enrichment, deep cell diagnosis, isolation of cytoplasmic contents and proteins, etc. the investments and expenditure on cell-based research have increased significantly. Thus, it is an integral factor responsible for the proliferation of the segment.

The research organizations are focusing on finding a better alternative for current cell analytical techniques. Flow cytometry is a major tool for in-depth study and development of cell-based assays. Research and academic institutes tend to invest more in this sector, thus driving the flow cytometry market growth.

The key market players are Agilent Technologies, Apogee Flow Systems, Beckman Coulter (A Subsidiary of Danaher), Cytonome St, Thermo Fisher Scientific, etc. Agilent Technologies and Thermo Fisher Scientific are expected to have a major market share owing to advanced equipment and methods.

FutureWise Key Takeaways:

By Technology 

  • Cell-based Flow Cytometry
  • Bead-based Flow Cytometry

By Product and Service 

  • Reagents and Consumables
  • Instruments
    • Cell Analyzers
      • High-range
      • Mid-range
      • Low-range
    • Cell Sorters
      • High-range
      • Mid-range
      • Low-range
  • Services
  • Software
  • Accessories

By Application

  • Research Applications
    • Pharmaceuticals and Biotechnology
      • Drug Discovery
      • Stem Cell Research
      • In Vitro Toxicity Testing
    • Immunology
    • Cell Sorting
    • Apoptosis
    • Cell Cycle Analysis
    • Cell Viability
    • Cell Counting
    • Other Research Applications
  • Clinical Applications
    • Cancer Diagnostics
    • Hematology
    • Immunodeficiency Diseases
    • Organ Transplantation
    • Other Clinical Applications
  • Industrial Applications

By End User

  • Academic & Research Institutes
  • Hospitals & Clinical Testing Laboratories
  • Pharmaceutical & Biotechnology Companies

By Region

  • North America
  • Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

The Asia-Pacific region is anticipated to exhibit the highest growth rate in the flow cytometry market, driven by increasing adoption in clinical applications and growing collaborations between industry and academia. Countries like China, Japan, and India are investing in healthcare infrastructure and research capabilities, creating lucrative opportunities for market expansion .

North America currently holds the largest market share, primarily due to its well-established healthcare system, robust research environment, and presence of leading market players. The region's focus on personalized medicine and advanced diagnostics continues to drive demand for flow cytometry technologies

Major players included in the Flow Cytometry Market:

  • Becton, Dickinson and Company
  • Beckman Coulter (A Subsidiary of Danaher)
  • Thermo Fisher Scientific
  • Merck KGaA
  • Luminex Corporation
  • Agilent Technologies
  • Sony Biotechnology (A Subsidiary of Sony Corporation of America)
  • Cytonome/St, LLC Laboratories
  • Miltenyi Biotec
  • Enzo Life Sciences, Inc. (A Subsidiary of Enzo Biochem)
  • Sysmex Partec (A Subsidiary of Sysmex Corporation)
  • Biomérieux SA
  • Stratedigm, Inc.
  • Apogee Flow Systems
  • Cytek Biosciences, Inc.
  • Sartorius AG
  • Union Biometrica, Inc.
  • Nanocellect Biomedical, Inc.
  • On-Chip Biotechnologies Co., Ltd.

Recent Developments by Leading Companies

Becton, Dickinson and Company (BD): In March 2023, BD launched the BD FACSDiscover S8 Cell Sorter, the world's first spectral cell sorter with high-speed cell imaging. This innovation integrates advanced spectral flow cytometry with BD’s CellView Image Technology, allowing real-time spatial and morphological analysis of cells during sorting.

Agilent Technologies: In May 2024, Agilent launched the NovoCyte Opteon Spectral Flow Cytometer, offering configurations ranging from three to five lasers and supporting up to 73 high-quality detectors. This instrument is designed to acquire, analyze, and report flow data from basic research to drug discovery and therapy development.

Sony Corporation: In October 2023, Sony introduced the FP7000 spectral cell sorter, supporting high-speed, high-parameter sorting with more than 44 colors. The system leverages patented spectral technology-based optics, advanced electronics, and fluidics to facilitate streamlined workflows.

Sysmex: In May 2023, Sysmex launched its Clinical Flow Cytometry System in Japan, which includes the Flow Cytometer XF-1600 and Sample Preparation System PS-10, along with antibody reagents and related products. This system aims to enhance workflow efficiency in clinical laboratories by minimizing manual tasks and promoting standardization.

Objectives of the Study:

  • To provide with an exhaustive analysis on the Flow Cytometry Market By Technology, By Product and Service, By Application, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com